Donald James Scotti

Keine laufenden Positionen mehr

75 Jahre

Health Technology

Consumer Services

Profil

Donald James Scotti formerly worked at Sweet Spot Productions, Inc., as President & Chief Executive Officer in 2010, Sycamore Entertainment Group, Inc., as President & Director, ImaRx Therapeutics, Inc., as President in 2010, Kaleidoscope Films Group LLC, as Vice President & Producer in 2005, and After Dark Films, as Executive Vice President.

Ehemalige bekannte Positionen von Donald James Scotti

Unternehmen	Position	Ende
ImaRx Therapeutics, Inc. ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA	Präsident	29.11.2010
Sweet Spot Productions, Inc.	Präsident	01.01.2010
Kaleidoscope Films Group LLC	Corporate Officer/Principal	01.01.2005
After Dark Films	Corporate Officer/Principal	-
SYCAMORE ENTERTAINMENT GROUP, INC.	Präsident	-

Sehen Sie sich die Erfahrung von Donald James Scotti im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Donald James Scotti im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
SYCAMORE ENTERTAINMENT GROUP, INC.	Consumer Services

Private Unternehmen	4
ImaRx Therapeutics, Inc. ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA	Health Technology
Sweet Spot Productions, Inc.
Kaleidoscope Films Group LLC
After Dark Films

Sehen Sie sich die Unternehmensverbindungen an

Börse
Insiders
Donald James Scotti